Phase 3 biotech developing stem cell therapies for hematologic malignancies.
Industry: Health Care
First Day Return: +5.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/28/2018 |
Offer Price | $8.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/26/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Jerusalem, Israel |
Founded | 1998 |
Employees at IPO | 52 |
Website www.gamida-cell.com |